U.S. markets closed
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • Dow 30

    29,910.37
    +37.90 (+0.13%)
     
  • Nasdaq

    12,205.85
    +111.44 (+0.92%)
     
  • Russell 2000

    1,855.27
    +10.25 (+0.56%)
     
  • Crude Oil

    45.53
    -0.18 (-0.39%)
     
  • Gold

    1,781.90
    -23.60 (-1.31%)
     
  • Silver

    22.64
    -0.81 (-3.44%)
     
  • EUR/USD

    1.1963
    +0.0050 (+0.42%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • GBP/USD

    1.3305
    -0.0051 (-0.38%)
     
  • USD/JPY

    104.0390
    -0.2110 (-0.20%)
     
  • BTC-USD

    17,006.33
    +281.53 (+1.68%)
     
  • CMC Crypto 200

    332.90
    -4.60 (-1.36%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

Cara: 3Q Earnings Snapshot

·1 min read

STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Monday reported a loss of $16.5 million in its third quarter.

On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 35 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 68 cents per share.

The biotechnology company posted revenue of $9.3 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $5 million.

Cara shares have fallen almost 10% since the beginning of the year. In the final minutes of trading on Monday, shares hit $14.54, a decline of 30% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA